Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3795142, 11 pages
https://doi.org/10.1155/2017/3795142
Research Article

High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease

1Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy
2Vascular and Renal Translational Research Group, Institut de Recerca Biomedica de Lleida (IRBLleida), Lleida, Spain
3Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, Hospital Universitari Arnau de Vilanova, Lleida, Spain
4Statistics Department, IRBLleida, Lleida, Spain
5Sistemes Renals, Lleida, Spain
6Department of Nephrology, Hospital Universitari Arnau de Vilanova, Lleida, Spain
7Department of Endocrinology and Nutrition, CIBER of Diabetes and Associated Metabolic Diseases, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Correspondence should be addressed to Maria Vittoria Arcidiacono; moc.liamtoh@ikcivicra and Mercè Borràs; tac.tacneg@sci.adiell.sarrobmm

Received 4 August 2016; Revised 30 October 2016; Accepted 14 November 2016; Published 4 January 2017

Academic Editor: Mauro Vaccarezza

Copyright © 2017 Maria Vittoria Arcidiacono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Daly, “Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK consensus conference on early chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 22, supplement 9, pp. ix19–ix25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Clinical epidemiology of cardiovascular disease in chronic renal disease,” American Journal of Kidney Diseases, vol. 32, no. 5, supplement 3, pp. S112–S119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. R. N. Foley, P. S. Parfrey, and M. J. Sarnak, “Epidemiology of cardiovascular disease in chronic renal disease,” Journal of the American Society of Nephrology, vol. 9, no. 12, supplement, pp. S16–S23, 1998. View at Google Scholar · View at Scopus
  5. W. B. Kannel, T. R. Dawber, A. Kagan, N. Revotskie, and J. Stokes III, “Factors of risk in the development of coronary heart disease—six year follow-up experience. The Framingham Study,” Annals of Internal Medicine, vol. 55, pp. 33–50, 1961. View at Google Scholar
  6. K. E. Sorensen, D. S. Celermajer, D. Georgakopoulos, G. Hatcher, D. J. Betteridge, and J. E. Deanfield, “Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level,” The Journal of Clinical Investigation, vol. 93, no. 1, pp. 50–55, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Gokce, J. F. Keaney Jr., L. M. Hunter, M. T. Watkins, J. O. Menzoian, and J. A. Vita, “Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study,” Circulation, vol. 105, no. 13, pp. 1567–1572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Maio, A. Sciacqua, R. Bruni et al., “Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 3, pp. 648–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Caprio, C. Mammi, and G. M. C. Rosano, “Vitamin D: a novel player in endothelial function and dysfunction,” Archives of Medical Science, vol. 8, no. 1, pp. 4–5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Shuto, Y. Taketani, R. Tanaka et al., “Dietary phosphorus acutely impairs endothelial function,” Journal of the American Society of Nephrology, vol. 20, no. 7, pp. 1504–1512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Perticone, R. Maio, R. Di Paola et al., “Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 17, no. 3, pp. 181–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Herrmann, L. O. Lerman, M. Rodriguez-Porcel et al., “Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia,” Cardiovascular Research, vol. 51, no. 4, pp. 762–766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kaiser, B. Younge, J. Björnsson, J. J. Goronzy, and C. M. Weyand, “Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells,” The American Journal of Pathology, vol. 155, no. 3, pp. 765–774, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Bouïs, Y. Kusumanto, C. Meijer, N. H. Mulder, and G. A. P. Hospers, “A review on pro- and anti-angiogenic factors as targets of clinical intervention,” Pharmacological Research, vol. 53, no. 2, pp. 89–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-L. Wang, D. Chen, J. Lee et al., “Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice,” PLoS ONE, vol. 9, no. 2, Article ID e87284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M.-M. Zaruba, B. C. Huber, S. Brunner et al., “Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival,” Cardiovascular Research, vol. 77, no. 4, pp. 722–731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Oikawa, K. Hirotani, H. Ogasawara et al., “Inhibition of angiogenesis by vitamin D3 analogues,” European Journal of Pharmacology, vol. 178, no. 2, pp. 247–250, 1990. View at Publisher · View at Google Scholar
  20. D. J. Mantell, P. E. Owens, N. J. Bundred, E. B. Mawer, and A. E. Canfield, “1α,25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo,” Circulation Research, vol. 87, no. 3, pp. 214–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Iseki, M. Tatsuta, H. Uehara et al., “Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats,” International Journal of Cancer, vol. 81, no. 5, pp. 730–733, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. Shokravi, D. M. Marcus, J. Alroy, K. Egan, M. A. Saornil, and D. M. Albert, “Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma,” Investigative Ophthalmology & Visual Science, vol. 36, no. 1, pp. 83–87, 1995. View at Google Scholar · View at Scopus
  23. D. M. Albert, E. A. Scheef, S. Wang et al., “Calcitriol is a potent inhibitor of retinal neovascularization,” Investigative Ophthalmology & Visual Science, vol. 48, no. 5, pp. 2327–2334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Dunst, A. Becker, C. Lautenschläger et al., “Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF),” Strahlentherapie und Onkologie, vol. 178, no. 8, pp. 436–441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. I. Yilmaz, A. Sonmez, M. Saglam et al., “Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease,” Kidney International, vol. 75, no. 12, pp. 1316–1321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. Ritman and A. Lerman, “The dynamic vasa vasorum,” Cardiovascular Research, vol. 75, no. 4, pp. 649–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Stein, C. E. Korcarz, R. T. Hurst et al., “Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine,” Journal of the American Society of Echocardiography, vol. 21, no. 2, pp. 93–190, 2008. View at Publisher · View at Google Scholar
  28. P.-J. Touboul, M. G. Hennerici, S. Meairs et al., “Mannheim intima-media thickness consensus,” Cerebrovascular Diseases, vol. 18, no. 4, pp. 346–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. M. V. Arcidiacono, A. Traveset, E. Rubinat et al., “Microangiopathy of large artery wall: a neglected complication of diabetes mellitus,” Atherosclerosis, vol. 228, no. 1, pp. 142–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. V. Arcidiacono, E. Rubinat, M. Borras et al., “Left carotid adventitial vasa vasorum signal correlates directly with age and with left carotid intima-media thickness in individuals without atheromatous risk factors,” Cardiovascular Ultrasound, vol. 13, no. 1, article 20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. V. Arcidiacono, E. Rubinat, E. Ortega, A. Betriu, E. Fernández, and D. Mauricio, “Pseudo-enhancement does not explain the increased carotid adventitial vasa vasorum signal in diabetic patients,” Atherosclerosis, vol. 229, no. 2, pp. 459–461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Magnoni, S. Coli, M. M. Marrocco-Trischitta et al., “Contrast-enhanced ultrasound imaging of periadventitial vasa vasorum in human carotid arteries,” European Journal of Echocardiography, vol. 10, no. 2, pp. 260–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. U. K. A. Sampson, F. E. Harrell, S. Fazio et al., “Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population,” Echocardiography, vol. 32, no. 2, pp. 264–270, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Magnoni, L. Dagna, S. Coli, D. Cianflone, M. G. Sabbadini, and A. Maseri, “Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound,” Circulation: Cardiovascular Imaging, vol. 4, no. 2, pp. e1–e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M.-X. Tang and R. J. Eckersley, “Nonlinear propagation of ultrasound through microbubble contrast agents and implications for imaging,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 53, no. 12, pp. 2406–2415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. R. D. C. Team, R: A Language and Environment for Statistical Computing, 2011, http://www.R-project.org/.
  37. S. Chaubey, D. Nitsch, D. Altmann, and S. Ebrahim, “Differing effect of modifiable cardiovascular risk factors on intima-media thickening and plaque formation at different sites of the arterial vasculature,” Heart, vol. 96, no. 19, pp. 1579–1585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Espeland, R. Tang, J. G. Terry, D. H. Davis, M. Mercuri, and J. R. Crouse III, “Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery,” Stroke, vol. 30, no. 5, pp. 1047–1055, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Luo, Y. Yang, T. Cao, and Z. Li, “Differences in left and right carotid intima-media thickness and the associated risk factors,” Clinical Radiology, vol. 66, no. 5, pp. 393–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. L. Bots, A. Hofman, A. M. De Bruyn, P. T. V. M. De Long, and D. E. Grobbee, “Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 13, no. 1, pp. 64–69, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Fisher and S. Fieman, “Geometric factors of the bifurcation in carotid atherogenesis,” Stroke, vol. 21, no. 2, pp. 267–271, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Gnasso, A. Pujia, C. Irace, and P. L. Mattioli, “Increased carotid arterial wall thickness in common hyperlipidemia,” Coronary Artery Disease, vol. 6, no. 1, pp. 57–63, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. E. K. Kabagambe, J. M. Ordovas, M. Y. Tsai et al., “Smoking, inflammatory patterns and postprandial hypertriglyceridemia,” Atherosclerosis, vol. 203, no. 2, pp. 633–639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Betriu, M. Martinez-Alonso, M. V. Arcidiacono et al., “Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study,” Nephrology Dialysis Transplantation, vol. 29, no. 7, pp. 1415–1422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. M. Tehrani, J. M. Gardin, D. Yanez et al., “Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study,” Atherosclerosis, vol. 231, no. 2, pp. 246–251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Tian, S. Hu, X. Han et al., “Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology,” Inflammation, vol. 35, no. 4, pp. 1530–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. T. Vlagopoulos, H. Tighiouart, D. E. Weiner et al., “Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3403–3410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. B. Drüeke, F. Locatelli, N. Clyne et al., “Normalization of hemoglobin level in patients with chronic kidney disease and anemia,” The New England Journal of Medicine, vol. 355, no. 20, pp. 2071–2084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. K. Singh, L. Szczech, K. L. Tang et al., “Correction of anemia with epoetin alfa in chronic kidney disease,” The New England Journal of Medicine, vol. 355, no. 20, pp. 2085–2098, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. D. A. Goodkin, D. S. Fuller, B. M. Robinson et al., “Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients,” Journal of the American Society of Nephrology, vol. 22, no. 2, pp. 358–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. R. J. Bernardi, C. S. Johnson, R. A. Modzelewski, and D. L. Trump, “Antiproliferative effects of 1α,25-dihydroxyvitamin D3 and vitamin D analogs on tumor-derived endothelial cells,” Endocrinology, vol. 143, no. 7, pp. 2508–2514, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Dusso, M. V. Arcidiacono, J. Yang, and M. Tokumoto, “Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality,” Journal of Steroid Biochemistry and Molecular Biology, vol. 121, no. 1-2, pp. 193–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Cheng and D. Coyne, “Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease,” Therapeutics and Clinical Risk Management, vol. 2, no. 3, pp. 297–301, 2006. View at Publisher · View at Google Scholar · View at Scopus